A men wearing a mask walk at the Shanghai Stock Exchange building at the Pudong financial district in Shanghai, China, as the country is hit by an outbreak of a new coronavirus, February 3, 2020.
REUTERS/Aly Song/File PhotoSHANGHAI, Aug 14 (Reuters) - The Shanghai Stock Exchange has urged bankers to pay close attention to the marketing practices of Chinese drug and medical equipment makers seeking initial public offerings (IPOs) amid an escalating anti-corruption drive in the sector, sources said.
The Shanghai exchange declined to comment.
Bankers should carefully examine if the company, controlling shareholders or actual controllers conduct bribery in marketing activities, the exchange said in the publication.
The bourse also asked bankers to check the authenticity of the marketing expenses and urged companies to fully disclose information in their prospectus.
Persons:
Aly, Christian Schmollinger
Organizations:
Shanghai Stock Exchange, REUTERS, bourse, Reuters, Bankers, Shanghai, Thomson
Locations:
Pudong, Shanghai, China